Frontiers Journal of Cancer Research & Therapeutics (FJCRT) is a broad scope open access academic and professional cancer journal affiliated to FM Publishers that aims to publish scientific manuscripts based on different types of cancer, cancer research, it's treatment, diagnosis, prevention, cancer diet.
As, it is a broad scope Cancer/Oncology journal it covers subject such as different types of cancer eg. Adeno Carcinoma, Enchondroma, Hepatocellular Carcinoma, Renal Cell Carcinoma, Breast Cancer, Prostrate Cancer, Colorectal Cancer, Parosteal Osteosarcoma, Chordomas, Brain Cancer, Lung Cancer, Head & Neck Cancer, Blood Cancer, Skin Cancer, Bladder Cancer, Ovarian Cancer, Mouth Cancer, Eye Melanoma, Anal Cancer, Thoracic Cancer, Stomach Cancer, Womb Cancer, Vaginal Cancer, Cervical Cancer, Pancreatic Cancer, Testicular Cancer, Thyroid Cancer, Uterine Cancer, Lip Cancer, Throat Cancer, Tongue Cancer, Tonsil Cancer, Ductal Carcinoma In Situ, Colon Cancer, Kidney Cancer, Liver Cancer, Adenoma, Osteogenic Sarcoma, Tumors, Radiation Therapy, Chemotherapy, Chemoside Effects, Chemotherapeutic Agents, Targeted Therapy, Cancer Surgery, Application of Nanotechnology for Cancer Treatment, Breast Reconstruction Surgery, Oncology Translational Research, 3D Mammograms, Aromatase Inhibitors, Scintimammography, Oncoplastic Surgery, Cancer Screening, Cancer and Nutrition, Naturopathic Treatments, Exercise and Cancer, Aromatherapy and Cancer, Yoga and Cancer, Stem Cell Transplants for Cancer Prevention, Alternative Cancer Medicines, Anticancer Drugs, Antitumor Antibiotics, Antimetabolites, Antineoplastic Agents, Avastin, Carcinogens, Hormonal Drugs for Cancer Therapy, Topoisomerase Inhibitors, Pharmacology of Cancer Drugs, Bone Marrow Stem Cell Transplant, Oncologic Interventional Radiology, Abdominal Interventional Radiology, Pediatric Radiology, Musculoskeletal Radiology, Cancer Clinical Trials, Cancer Management, Neuro-Oncology, Brain Metastasis, Cancer Risk, Cancer Vaccine Development & Strategies, Biopsy, Programmed Cell Death, Tumor Associated Inflammation, Antiangiogenic Therapies, Genetics and Epigenetics, Orthopedic Oncology, Chondrosarcoma, Chordoma, Osteosarcoma, Ewing's sarcoma, Metastatic bone cancer, Adamantinoma, Osteonecrosis, Primary Bone Tumors, Osseous and Chondromatous Neoplasia, Tumours of Bone, Secondary Bone Tumors, Primary Bone Tumors, Enchondroma, Aneurysmal Bone Cyst, Giant Cell Tumor of Bone, Cryosurgery, Osteoma, Fibrous Dysplasia of Bone, Osteochondrodysplasia, Osteocartilaginous Exostoses, Cancer Radio Immunotherapy, Translational Cell Carcinoma, Monoclonal Antibody, Oncogenes, Use of Radium 223 Dichloride, DNA Repair in Cancer Therapy, Tumor Suppressor Gene, Addiction & Cancer, Spinal Tumors, Cancer Biomarkers, Veterinary Oncology,
The main objective of the journal is to disseminate the scientific work, publication, education and exchange of ideas globally. The Journal provides authors with a platform to contribute their findings and help raise awareness among readers on Cancer, cancer risk, treatment and cure. The primary goal of the journal is to maintain high quality of publications and to serve international scientific and clinical communities to strengthen links between science and policy and to stimulate and enhance the quality of debate.
The journal caters to Oncologists, Pathologists, Hematologists, Gastroenterologists, Endocrinologists, Urologists, Gynecologists, Radiologists, Epidemiologists, Pulmonologists, Health Care Professionals, University Professors and Researchers in basic science. The journal accepts Original Articles, Reviews, Mini Review, Case Reports, Clinical Images, Rapid Communication and Commentary covering all aspects of Cancer/Oncology Research & Therapeutics. This is an open access journal providing easy access to its viewers globally.
Authors who would like to discuss the potential interest in a manuscript may contact Editorial office. This journal is an attempt from our side to bridge the knowledge gaps across a wide range of bench-to-bedside investigation and encourages original research works to make a significant contribution towards advancing knowledge and supports evidence based clinical practice. We believe that this journal will bring innovation in the field of Cancer Research & Therapeutics/Oncology.
So. as a token of respect & gratitude we would publish quality research work for free or at a very nominal price.
We have two options, medically and emotionally; give up or fight like hell. Fight Cancer (Lance Armstrong).